Sierra-Campos Erick, Valdez-Solana Mónica, Avitia-Domínguez Claudia, Campos-Almazán Mara, Flores-Molina Ismael, García-Arenas Guadalupe, Téllez-Valencia Alfredo
Facultad de Ciencias Químicas, Universidad Juárez del Estado de Durango Campus Gómez Palacio, Avenida Artículo 123 S/N, Fracc, Filadelfia, Gómez Palacio 35010, Mexico.
Facultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Avenida Universidad y Fanny Anitúa S/N, Durango 34000, Mexico.
Antioxidants (Basel). 2020 Sep 8;9(9):840. doi: 10.3390/antiox9090840.
In our study, we aimed to evaluate the effects of leaves extract on rat paraoxonase 1 (rPON1) and catalase (rCAT) activities in alloxan-induced diabetic rats. Our study included three groups; group C (control, n = 5); group D (diabetic, n = 5); and group DM ( extract-supplemented diabetic rats, n = 5). Daily oral administration of extract at 200 mg/kg doses produced an increase in endogenous antioxidants. Serum rPON1 (lactonase) and liver cytosol catalase activities were determined by a spectrophotometric assay using progress curve analysis. We found a decrease in the Vm value of rPON1 in diabetic rats, but dihydrocoumarin (DHC) affinity (Km) was slightly increased. The value of Vm for the DM group was found to be reduced approximately by a factor of 3 compared with those obtained for group C, whereas Km was largely changed (96 times). Catalase activity was significantly higher in the DM group. These data suggest that the activation of rPON1 and rCAT activities by extracts may be mediated via the effect of the specific flavonoids on the enzyme structure. In addition, through molecular blind docking analysis, rPON1 was found to have two binding sites for flavonoids. In contrast, flavonoids bound at four sites in rCAT. In conclusion, the data suggest that compounds from leaves extract were able to influence the catalytic activities of both enzymes to compensate for the changes provoked by diabetes in rats.
在我们的研究中,我们旨在评估叶提取物对四氧嘧啶诱导的糖尿病大鼠体内大鼠对氧磷酶1(rPON1)和过氧化氢酶(rCAT)活性的影响。我们的研究包括三组:C组(对照组,n = 5);D组(糖尿病组,n = 5);以及DM组(补充提取物的糖尿病大鼠组,n = 5)。以200mg/kg剂量每日口服提取物可使内源性抗氧化剂增加。通过使用进程曲线分析的分光光度法测定血清rPON1(内酯酶)和肝细胞溶胶过氧化氢酶活性。我们发现糖尿病大鼠中rPON1的Vm值降低,但二氢香豆素(DHC)亲和力(Km)略有增加。发现DM组的Vm值与C组相比大约降低了3倍,而Km有很大变化(96倍)。DM组中的过氧化氢酶活性显著更高。这些数据表明,叶提取物对rPON1和rCAT活性的激活可能是通过特定类黄酮对酶结构的作用介导的。此外,通过分子盲对接分析,发现rPON1有两个类黄酮结合位点。相比之下,类黄酮在rCAT中有四个结合位点。总之,数据表明叶提取物中的化合物能够影响这两种酶的催化活性,以补偿糖尿病在大鼠中引发的变化。